NSE · TARSONS · Healthcare
Tarsons Products Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹100 Cr with net profit ₹3 Cr — a 3.08% net margin, versus 0.79% the period before.
Shareholding
As of 2026-09-30
- Promoter47.3%
- Public51.53%
- FII0.55%
- DII0.61%
80,867 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.28× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Miscellaneous · ranked #106 of 556 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| National Stock Exchange Of India Ltd. | ₹4,92,537 Cr | 44.59 | 11.77 | 26.24% | 62.66% |
| Adani Ports & Special Economic Zone Ltd. | ₹4,38,513 Cr | 31.72 | 4.29 | 13.33% | 31.98% |
| Eternal Limited | ₹3,50,935 Cr | 713.04 | 11.23 | 1.58% | 0.63% |
| BSE Limited | ₹1,60,613 Cr | 52.11 | 20.2 | 38.76% | 53.09% |
| Vedanta Aluminium Metal Limited | ₹1,48,517 Cr | 7.86 | 6.44 | 80.07% | 23.43% |
| One 97 Communications Ltd. | ₹1,24,615 Cr | 148.65 | 7.52 | 5.15% | 8.95% |
| GAIL (India) Ltd. | ₹1,23,612 Cr | 9.79 | 1.27 | 13.05% | 7.91% |
| Meesho Limited | ₹1,19,049 Cr | — | 28.31 | -21.93% | -6.19% |
| GMR Airports Limited | ₹1,05,544 Cr | 165 | 0 | -25.64% | 3.13% |
| Multi Commodity Exchange of India Ltd. | ₹94,857 Cr | 52.73 | 27.05 | 51.22% | 58.86% |
| Tarsons Products Limited(this company) | ₹1,678 Cr | 206.18 | 2.66 | 1.17% | 1.61% |
AI analysis
AI-generated · google/gemini-2.5-flashTarsons Products Limited is listed with a market capitalization of Rs 1497 Cr. The company reported a revenue of Rs 408.37 Cr and a profit margin of 338.9%. Its earnings per share (EPS) stands at Rs 2.83, with a return on equity (ROE) of 225.7%. The debt-to-equity ratio is 0.49.
Positives
- +Revenue grew 32.4% to Rs 408.37 Cr for the fiscal year ending March 2025.
- +The profit margin for the latest reported period is high at 338.9%.
- +Return on equity (ROE) is 225.7%.
Negatives
- −The promoter holding decreased from 47.3064% as of June 30, 2022 to 47.3026% as of March 31, 2026.
- −Return on capital employed (ROCE) is relatively low at 4.09%.
- −The stock is under ST-ASM · ASM 1 surveillance.
- −Foreign Institutional Investor (FII) holding has significantly decreased from 9.3285% in June 2022 to 0.87% in March 2026.
Financial Performance
For the fiscal year ending March 2025, Tarsons Products Limited reported a revenue of Rs 408.37 Cr, marking a growth of 32.4%. The net profit for the same period was Rs 29.77 Cr, with an EPS of Rs 5.6. Quarterly revenue for March 2026 was Rs 120.93 Cr, with a net profit of Rs 4.18 Cr.
Profitability & Returns
The company demonstrated a profit margin of 338.9%. Return on equity (ROE) stood at 225.7%, while return on capital employed (ROCE) was 4.09%. The earnings per share (EPS) for the fiscal year ending March 2025 was Rs 5.6.
Balance Sheet
Tarsons Products Limited has a book value per share of Rs 119.29. The company's debt-to-equity ratio is 0.49, indicating its reliance on debt financing relative to equity. No dividend yield was reported.
Ownership & Pledges
As of March 31, 2026, promoter shareholding was 47.30%, while public shareholding was 51.64%. Foreign Institutional Investors (FIIs) held 0.87% and Domestic Institutional Investors (DIIs) held 0.19%. There were no promoter pledges reported.
Regulatory & Surveillance
The stock is currently under ST-ASM · ASM 1 surveillance, with measures including ST-ASM and ST-ASM.
Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.